Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR000754)
Formula
CYP
SVG example
Hydroxylation
Reactant Deferasirox Product Deferasirox metabolite M1
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 (CYP) DME Info
Metabolic Type Oxidation - Hydroxylation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000756 Deferasirox Deferasirox metabolite M2 Oxidation - Hydroxylation Deferasirox [1], [2]
MR000755 Deferasirox Deferasirox metabolite M3 Conjugation - Glucuronidation Deferasirox [1]
MR000758 Deferasirox Deferasirox metabolite M4 Conjugation - O-Glucuronidation Deferasirox [3]
MR000757 Deferasirox Deferasirox metabolite M6 Conjugation - O-Glucuronidation Deferasirox [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000753 Deferasirox metabolite M1 Deferasirox metabolite M7 Conjugation - Sulfation Deferasirox [2]
References
1 Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state Drug Metab Dispos. 2010 May;38(5):808-16. doi: 10.1124/dmd.109.030833.
2 Pharmacokinetics, distribution, metabolism, and excretion of deferasirox and its iron complex in rats Drug Metab Dispos. 2008 Dec;36(12):2523-38. doi: 10.1124/dmd.108.022962.
3 Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside Biochem Pharmacol. 1983 Apr 1;32(7):1327-8. doi: 10.1016/0006-2952(83)90293-9.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.